340B

May 18, 2023

CLIENT ALERT: House Health Subcommittee Recommends Bills That Would Eliminate 340B Margin on Medicaid Managed Care Drugs, Require Reporting on 340B Utilization and Savings

2023-06-06T15:39:50-04:00By |Categories: Client Alerts, Health Care|Tags: , , |

The Health Subcommittee of the House of Representatives’ Energy and Commerce Committee held a markup hearing on May 17, 2023 to discuss a series of bills relating to transparency and competition in [...]

February 01, 2023

CLIENT ALERT: Multi-Pharmacy 340B Contract Pharmacy Programs in Serious Jeopardy After Third Circuit Ruling

2023-06-06T15:42:06-04:00By |Categories: Client Alerts, Health Care|Tags: , , , |

The United States Court of Appeals for the Third Circuit ruled on Monday in favor of drug manufacturers AstraZeneca, Sanofi and Novo Nordisk in their challenge against attempts by the Health Resources [...]

December 10, 2020

Supreme Court Rules States Can Regulate Pharmacy Reimbursement Rates without Triggering ERISA Preemption in Important Case for 340B Reimbursement Protection

2023-11-13T11:57:12-05:00By |Categories: Articles, Blog, Health Care|Tags: , |

On December 10, 2020, the Supreme Court ruled in a unanimous decision (8-0) in Rutledge v. Pharmaceutical Care Management Association (PCMA)[1] that an Arkansas law that requires Pharmacy Benefit Managers (PBMs) to [...]

Go to Top